Halozyme Therapeutics | HALO - 부채에 대한이자 비용





부채에 대한이자 비용 변화 날짜
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amarin USD 3K 5K 2024-12
Amgen USD 653M 32M 2025-12
Baxter International USD 58M 14M 2025-09
Cara Therapeutics 43.75M 4.8M 2025-06
Cytokinetics USD 30.33M 4.01M 2025-12
DBV Technologies USD 461K 323.71K 2025-03
Eli Lilly USD 114.7M 134.3M 2025-09
Esperion Therapeutics USD 22.64M 585K 2025-12
Halozyme Therapeutics USD 4.91M 615K 2025-12
Intrexon USD 2K 5K 2024-06
Ionis Pharmaceuticals USD 18M 0 2025-12
MannKind USD 13.87M 6.54M 2025-12
Minerva Neurosciences USD 2.31M 60K 2024-06
Nektar Therapeutics USD 6.02M 420K 2024-09
Pfizer USD 711M 59M 2025-12
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
United Therapeutics USD 3.1M 100K 2025-12
Vanda Pharmaceuticals 601.14M 23.61M 2025-09